Agilent Technologies (NYSE:A) Shares Gap Up to $133.42

Agilent Technologies, Inc. (NYSE:A) gapped up before the market opened on Tuesday . The stock had previously closed at $133.42, but opened at $137.61. Agilent Technologies shares last traded at $134.69, with a volume of 150,502 shares.

Analysts Set New Price Targets

Several analysts recently issued reports on A shares. UBS Group decreased their price objective on shares of Agilent Technologies from $155.00 to $141.00 and set a “neutral” rating for the company in a report on Thursday, May 30th. Robert W. Baird decreased their price objective on shares of Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating for the company in a report on Thursday, May 30th. Bank of America increased their price target on shares of Agilent Technologies from $134.00 to $140.00 and gave the company a “neutral” rating in a report on Tuesday, June 25th. Evercore ISI increased their price target on shares of Agilent Technologies from $126.00 to $130.00 and gave the company an “in-line” rating in a report on Tuesday, July 2nd. Finally, TD Cowen reduced their price target on shares of Agilent Technologies from $163.00 to $153.00 and set a “buy” rating for the company in a report on Thursday, May 30th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $138.06.

Agilent Technologies Stock Down 0.4 %

The firm has a market cap of $38.77 billion, a price-to-earnings ratio of 31.40, a PEG ratio of 4.48 and a beta of 1.05. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.64 and a current ratio of 2.15. The business’s 50-day moving average is $136.10 and its 200-day moving average is $137.55.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 29th. The medical research company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.03. The business had revenue of $1.57 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The firm’s revenue for the quarter was down 8.4% on a year-over-year basis. During the same quarter last year, the company posted $1.27 EPS. On average, equities analysts predict that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd will be given a $0.236 dividend. This represents a $0.94 annualized dividend and a yield of 0.71%. The ex-dividend date is Tuesday, July 2nd. Agilent Technologies’s payout ratio is presently 22.22%.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, SVP Dominique Grau sold 15,000 shares of the firm’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $133.28, for a total value of $1,999,200.00. Following the completion of the sale, the senior vice president now owns 49,486 shares in the company, valued at approximately $6,595,494.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Agilent Technologies news, SVP Dominique Grau sold 15,000 shares of the firm’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $133.28, for a total value of $1,999,200.00. Following the completion of the sale, the senior vice president now owns 49,486 shares in the company, valued at approximately $6,595,494.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $130.00, for a total transaction of $254,540.00. Following the sale, the chief executive officer now owns 25,185 shares of the company’s stock, valued at approximately $3,274,050. The disclosure for this sale can be found here.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Livelsberger Financial Advisory bought a new position in Agilent Technologies in the fourth quarter valued at approximately $26,000. MV Capital Management Inc. lifted its stake in Agilent Technologies by 120.7% in the fourth quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock valued at $27,000 after buying an additional 105 shares in the last quarter. VisionPoint Advisory Group LLC bought a new position in Agilent Technologies in the fourth quarter valued at approximately $29,000. Rise Advisors LLC raised its holdings in shares of Agilent Technologies by 527.8% in the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock valued at $33,000 after purchasing an additional 190 shares during the last quarter. Finally, YHB Investment Advisors Inc. acquired a new stake in shares of Agilent Technologies in the first quarter valued at approximately $34,000.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.